CNS involvement at the onset of primary hemophagocytic lymphohistiocytosis
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Objectives: To differentiate onset of CNS involvement in primary hemophagocytic lymphohistiocytosis (HLH) from that of other CNS inflammatory diseases and to identify early symptoms linked to abnormal cognitive outcome.
Methods: Forty-six children with primary HLH who had neurologic evaluation within 2 weeks and brain MRI within 6 months of diagnosis were included. Initial symptoms, CSF study, brain MRI, and neurologic outcome were assessed. Brain MRIs were compared with those of 44 children with acute disseminated encephalomyelitis (ADEM).
Results: At disease onset, 29 children (63%) had neurologic symptoms and 7 (15%) had microcephaly. Twenty-three (50%) children had abnormal CSF study, but only 15 (33%) had abnormal brain MRI. The latter showed that patients with HLH, unlike patients with ADEM, had symmetric periventricular lesions, without thalamic and brainstem involvement and with infrequent hyposignal intensity on T1. At the end of follow-up (3.6 ± 3.6 years), 17 of the 28 (61%) surviving patients had normal neurologic status, 5 (18%) had a severe neurologic outcome, and 6 (21%) had mild cognitive difficulties. Abnormal neurologic outcome was not influenced by age or type of genetic defect, but by the presence of neurologic symptoms, MRI lesions, or abnormal CSF study at onset. Early clinical and MRI symptoms may regress after treatment.
Conclusion: Neurologic symptoms are frequent at the onset of primary HLH and are mostly associated with abnormal CSF findings, but with normal brain MRI. In cases of abnormal brain MRI, the observed lesions differ from those of ADEM.
GLOSSARY
- ADEM=
- acute disseminated encephalomyelitis;
- CHS=
- Chediak-Higashi syndrome;
- CRF=
- case report form;
- FHLH=
- familial hemophagocytic lymphohistiocytosis;
- FLAIR=
- fluid-attenuated inversion recovery;
- GS=
- Griscelli syndrome;
- HLH=
- hemophagocytic lymphohistiocytosis;
- HPS=
- Hermansky-Pudlak syndrome;
- HSCT=
- hematopoietic stem cell transplantation;
- MTX=
- methotrexate;
- PID=
- primary immunodeficiencies;
- SE=
- spin-echo;
- WI=
- weighted image;
- XLP=
- X-linked lymphoproliferative syndrome
Footnotes
-
Editorial, page 1114
- Received June 8, 2011.
- Accepted September 23, 2011.
- Copyright © 2012 by AAN Enterprises, Inc.
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
More Online
Dr. Emily Gilmore and Dr. Rachel Beekman
► Watch
Related Articles
Topics Discussed
Alert Me
Recommended articles
-
Editorials
Lymphohistiocytosis in the brainRecognition of a potentially reversible aspect of primary HLHBrenda Banwell, Russell C. Dale et al.Neurology, March 14, 2012 -
Article
Pediatric CNS-isolated hemophagocytic lymphohistiocytosisLeslie A. Benson, Hojun Li, Lauren A. Henderson et al.Neurology: Neuroimmunology & Neuroinflammation, April 08, 2019 -
Articles
Differential diagnosis and evaluation in pediatric multiple sclerosisJin S. Hahn, Daniela Pohl, Mary Rensel et al.Neurology, April 16, 2007 -
Clinical/Scientific Notes
Progressive neurologic disorder: Initial manifestation of hemophagocytic lymphohistiocytosisClaire Murphy, Sira Nanthapisal, Kimberly Gilmour et al.Neurology, April 29, 2016